Photocure ASA

Oslo Stock Exchange PHO.OL

Photocure ASA EBT Margin for the year ending December 31, 2023: 1.95%

Photocure ASA EBT Margin is 1.95% for the year ending December 31, 2023, a 110.75% change year over year. EBT Ratio (Earnings Before Tax Ratio) is the fraction of earnings before taxes to total revenue, indicating the company's profitability before the impact of tax expenses.
  • Photocure ASA EBT Margin for the year ending December 31, 2022 was -18.09%, a -106.08% change year over year.
  • Photocure ASA EBT Margin for the year ending December 31, 2021 was -8.78%, a 32.22% change year over year.
  • Photocure ASA EBT Margin for the year ending December 31, 2020 was -12.95%, a -179.46% change year over year.
  • Photocure ASA EBT Margin for the year ending December 31, 2019 was 16.30%, a 180.60% change year over year.
Key data
Date EBT Margin Net Income Margin EBITDA Margin EBIT Margin
Market news
SV Wall Street
Oslo Stock Exchange: PHO.OL

Photocure ASA

CEO Mr. Daniel Schneider
IPO Date May 30, 2000
Location Norway
Headquarters Hoffsveien 4
Employees 102
Sector Healthcare
Industries
Pharmaceuticals Biotechnology Cleaning Supplies Cosmetics Drugstores & Retail Pharmacies Eyewear Personal Care Vaccines
Description

Photocure ASA, a specialty pharmaceutical company, engages in the research, development, production, distribution, marketing, and sale of pharmaceutical products in Nordic countries, Germany, France, Austria, the United Kingdom, the Netherlands, Italy, other European Countries, and the United States. The company offers Hexvix/Cysview for the detection and management of bladder cancer. It also develops Cevira for the treatment of human papilloma virus infection and precancerous lesions of the cervix. The company sells its products to pharmaceutical wholesalers, pharmacies, and hospitals through license partners. Photocure ASA was founded in 1993 and is headquartered in Oslo, Norway.

StockViz Staff

February 7, 2025

Any question? Send us an email